The strongest evidence for this position is derived from molecular genetic studies of the three genes (amyloid precursor protein, presenilin 1, and presenilin 2) that underlie familial AD cases, as they all modulate some aspect of Aβ metabolism, increasing the propensity of Aβ to aggregate [13-16]. Here, APP is linked to Alzheimer disease.